Literature DB >> 21875938

A consensus-based guideline defining clinical target volume for primary disease in external beam radiotherapy for intact uterine cervical cancer.

Takafumi Toita1, Tatsuya Ohno, Yuko Kaneyasu, Tomoyasu Kato, Takashi Uno, Kazuo Hatano, Yoshiki Norihisa, Takahiro Kasamatsu, Takeshi Kodaira, Ryoichi Yoshimura, Satoshi Ishikura, Masahiro Hiraoka.   

Abstract

OBJECTIVE: To develop a consensus-based guideline to define clinical target volume for primary disease (clinical target volume primary) in external beam radiotherapy for intact uterine cervical cancer.
METHODS: The working subgroup of the JCOG Radiation Therapy Study Group began developing a guideline for primary clinical target volume in November 2009. The group consisted of 10 radiation oncologists and 2 gynecologic oncologists. The process started with comparing the contouring on computed tomographic images of actual cervical cancer cases among the members. This was followed by a comprehensive literature review that included primary research articles and textbooks as well as information on surgical procedures. Extensive discussion occurred in face-to-face meetings (three occasions) and frequent e-mail communications until a consensus was reached.
RESULTS: The working subgroup reached a consensus on the definition for the clinical target volume primary. The clinical target volume primary consists of the gross tumor volume, uterine cervix, uterine corpus, parametrium, vagina and ovaries. Definitions for these component structures were determined. Anatomical boundaries in all directions were defined for the parametrium. Examples delineating these boundaries were prepared for the posterior border of the parametrium for various clinical situations (i.e. central tumor bulk, degree of parametrial involvement).
CONCLUSIONS: A consensus-based guideline defining the clinical target volume primary was developed for external beam radiotherapy for intact uterine cervical cancer. This guideline will serve as a template for radiotherapy protocols in future clinical trials. It may also be used in actual clinical practice in the setting of highly precise external beam radiotherapy, including intensity-modulated radiotherapy.

Entities:  

Mesh:

Year:  2011        PMID: 21875938     DOI: 10.1093/jjco/hyr096

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  21 in total

1.  Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.

Authors:  Jen-Yu Cheng; Eng-Yen Huang; Shun-Neng Hsu; Chong-Jong Wang
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

2.  Clinical evaluation of deep learning-based clinical target volume three-channel auto-segmentation algorithm for adaptive radiotherapy in cervical cancer.

Authors:  Chen-Ying Ma; Ju-Ying Zhou; Xiao-Ting Xu; Song-Bing Qin; Miao-Fei Han; Xiao-Huan Cao; Yao-Zong Gao; Lu Xu; Jing-Jie Zhou; Wei Zhang; Le-Cheng Jia
Journal:  BMC Med Imaging       Date:  2022-07-09       Impact factor: 2.795

3.  Obesity in patients with carcinoma cervix increases the risk of adverse events.

Authors:  Ramaiah Vinay Kumar; Suman Bhasker
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-26

4.  Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer.

Authors:  Yuki Mukai; Yumiko Minagawa; Hiromi Inoue; Akiko Sato; Kengo Matsui; Takanori Fukuda; Kazuya Onuma; Hideyuki Hongo; Ryosuke Shirata; Hironori Nagata; Harumitu Hashimoto; Tomio Inoue; Masaharu Hata; Motoko Omura
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

5.  Plan-Optimization Method for Central-shielding Pelvic Volumetric-modulated Arc Therapy for Cervical Cancer.

Authors:  Ryuta Hirai; Tomoaki Tamaki; Mitsunobu Igari; Y U Kumazaki; Shin-Ei Noda; Shingo Kato
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

6.  Clinical and dosimetric factors associated with the development of hematologic toxicity in locally advanced cervical cancer treated with chemotherapy and 3D conformal radiotherapy.

Authors:  Miguel Ángel Souto-Del Bosque; Miguel Ángel Cervantes-Bonilla; Gerardo Del Carmen Palacios-Saucedo
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-13

Review 7.  Radiotherapy for cervical cancer: Chilean consensus of the Society of Radiation Oncology.

Authors:  Felipe Carvajal; Claudia Carvajal; Tomás Merino; Verónica López; Javier Retamales; Evelyn San Martín; Freddy Alarcón; Mónica Cuevas; Francisca Barahona; Ignacio Véliz; Juvenal A Ríos; Sergio Becerra
Journal:  Rep Pract Oncol Radiother       Date:  2021-04-14

8.  A comparative planning study of step-and-shoot IMRT versus helical tomotherapy for whole-pelvis irradiation in cervical cancer.

Authors:  Imjai Chitapanarux; Ekkasit Tharavichitkul; Wannapa Nobnop; Somsak Wanwilairat; Roy Vongtama; Patrinee Traisathit
Journal:  J Radiat Res       Date:  2015-02-26       Impact factor: 2.724

9.  Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy.

Authors:  Avinash Badajena; Vijay Parshuram Raturi; Kirti Sirvastava; Hidehiro Hojo; Hajime Ohyoshi; Yanping Bei; Toshiya Rachi; Chen-Ta Wu; Taku Tochinai; Masayuki Okumura; Haiqin Zhang; Hirotaki Kouta; Pragya Verma; Geeta Singh; Abhishek Anand; Anjali Sachan
Journal:  Rep Pract Oncol Radiother       Date:  2020-02-22

10.  Image-guided brachytherapy (IGBT) combined with whole pelvic intensity-modulated radiotherapy (WP-IMRT) for locally advanced cervical cancer: a prospective study from Chiang Mai University Hospital, Thailand.

Authors:  Ekkasit Tharavichitkul; Somsak Wanwilairat; Somvilai Chakrabandhu; Pitchayaponne Klunklin; Wimrak Onchan; Damrongsak Tippanya; Wannapa Nopnop; Razvan Galalae; Imjai Chitapanarux
Journal:  J Contemp Brachytherapy       Date:  2013-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.